Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GLB1L3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KATNBL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
C1orf106 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP27C1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSC22D1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPHP3-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
IPO5P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBALD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYB5RL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLDN11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUCB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STXBP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LIX1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM88 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MFSD8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on